BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3050452)

  • 1. Botulinum neurotoxin types A, B & E: pH induced difference spectra.
    Datta A; DasGupta BR
    Mol Cell Biochem; 1988 Jun; 81(2):187-94. PubMed ID: 3050452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular dichroic and fluorescence spectroscopic study of the conformation of botulinum neurotoxin types A and E.
    Datta A; DasGupta BR
    Mol Cell Biochem; 1988 Feb; 79(2):153-9. PubMed ID: 3398838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular topography and secondary structure comparisons of botulinum neurotoxin types A, B and E.
    Singh BR; DasGupta BR
    Mol Cell Biochem; 1989 Mar; 86(1):87-95. PubMed ID: 2755458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial amino acid sequences of botulinum neurotoxins types B and E.
    Schmidt JJ; Sathyamoorthy V; DasGupta BR
    Arch Biochem Biophys; 1985 May; 238(2):544-8. PubMed ID: 3888113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.
    Dasgupta BR; Sugiyama H
    Infect Immun; 1976 Sep; 14(3):680-6. PubMed ID: 965092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin.
    Prabakaran S; Tepp W; DasGupta BR
    Toxicon; 2001 Oct; 39(10):1515-31. PubMed ID: 11478959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent structure of botulinum neurotoxin type B; location of sulfhydryl groups and disulfide bridge and identification of C-termini of light and heavy chains.
    Antharavally BS; DasGupta BR
    J Protein Chem; 1998 Jul; 17(5):417-28. PubMed ID: 9717738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichain structure of botulinum neurotoxin: identification of cleavage sites in types C, D, and F neurotoxin molecules.
    Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
    J Protein Chem; 1999 Nov; 18(8):885-92. PubMed ID: 10839626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E.
    Sathyamoorthy V; DasGupta BR
    J Biol Chem; 1985 Sep; 260(19):10461-6. PubMed ID: 4030755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin type E fragmented with endoproteinase Lys-C reveals the site trypsin nicks and homology with tetanus neurotoxin.
    Giménez JA; DasGupta BR
    Biochimie; 1990 Apr; 72(4):213-7. PubMed ID: 2116911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status of Cys residues in the covalent structure of botulinum neurotoxin types A, B, and E.
    Antharavally B; Tepp W; DasGupta BR
    J Protein Chem; 1998 Apr; 17(3):187-96. PubMed ID: 9588942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells.
    Bittner MA; DasGupta BR; Holz RW
    J Biol Chem; 1989 Jun; 264(18):10354-60. PubMed ID: 2732226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.
    Bandyopadhyay S; Clark AW; DasGupta BR; Sathyamoorthy V
    J Biol Chem; 1987 Feb; 262(6):2660-3. PubMed ID: 3029090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductive methylation of lysine residues of botulinum neurotoxin types A and B.
    Sathyamoorthy V; DasGupta BR
    Mol Cell Biochem; 1988 Sep; 83(1):65-72. PubMed ID: 3146688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is formation of visible channels in a phospholipid bilayer by botulinum neurotoxin type B sensitive to its disulfide?
    Flicker PF; Robinson JP; DasGupta BR
    J Struct Biol; 1999 Dec; 128(3):297-304. PubMed ID: 10633069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the molecular topography of the light and heavy chains of type A botulinum neurotoxin following their separation.
    Singh BR; DasGupta BR
    Biophys Chem; 1989 Nov; 34(3):259-67. PubMed ID: 2611349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.